Jaypirca: Uses, How It Works, and Common Side Effects

Jaypirca is used to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or mantle cell lymphoma that has come back or did not respond to treatment.

It is given to people who have already received at least 2 treatments for their cancer.

Jaypirca is a targeted cancer treatment, called a kinase inhibitor. It works by blocking a protein primarily found in B-cells called Bruton's tyrosine kinase which is involved in a pathway essential for the normal development, growth, and survival of B-cells.

In certain types of B-cell cancers, this protein is often overactive and blocking it helps to stop cancer cells from multiplying.

Jaypirca tablets are taken by mouth once a day.

Common Jaypirca side effects include tiredness, muscle, joint and bone pain, diarrhea, bruising, and cough.

This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

Always consult with your healthcare provider.